- $84.06m
- $63.59m
- $65.30m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 4.3 | ||
| Price to Tang. Book | 4.3 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -171.73% | ||
| Return on Equity | -89.74% | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 30th Jun | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 27.76 | 34.8 | 40.7 | 48.82 | 65.3 | n/a | 25 | 67.75% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
MEI Pharma, Inc. is a pharmaceutical company with a portfolio of several drug candidates that may offer novel and differentiated therapies. The Company's treasury initiative is anchored by Litecoin. The Company has discontinued the clinical development of voruciclib, while certain nonclinical activities related to its drug candidate assets continue to be conducted by it. As part of the review of strategic alternatives, the Company may consider options such as out-licensing opportunities for existing programs and merger and acquisition opportunities.
Directors
- Christine White NEC (69)
- Daniel Gold CEO (67)
- David Urso COO (57)
- Yomara Gomez-Naiden SVP
- Alejandro Ricart SVP
- Richard Ghalie OTH (64)
- Sujay Kango DRC (57)
- Charles Baltic IND (60)
- Cheryl Cohen IND (55)
- Frederick Driscoll IND (71)
- Nicholas Glover IND (52)
- Tamar Howson IND (73)
- Thomas Reynolds IND (62)
- Last Annual
- June 30th, 2024
- Last Interim
- March 31st, 2025
- Incorporated
- December 1st, 2000
- Public Since
- December 18th, 2003
- No. of Shareholders
- 321
- No. of Employees
- 28
- Sector
- Investment Banking & Investment Services
- Industry
- Financials
- Exchange
NASDAQ Capital Market- Shares in Issue
- 32,837,743
- Address
- 9920 Pacific Heights Blvd, Suite 150, SAN DIEGO, 92121
- Web
- https://litestrategy.com/
- Phone
- +1 8583697100
- Auditors
- BDO USA, P.C.
Upcoming Events for LITS
MEI Pharma Inc Annual Shareholders Meeting
Q2 2026 MEI Pharma Inc Earnings Release
Similar to LITS
Aether Holdings
NASDAQ Capital Market
Agora Digital Holdings
NASDAQ Capital Market
Agriforce Growing Systems
NASDAQ Capital Market
AlphaTON Capital
NASDAQ Capital Market
ALT5 Sigma
NASDAQ Capital Market
FAQ
What is the Lite Strategy share price?
As of Today at 21:46 UTC, shares in Lite Strategy are trading at $2.56. This share price information is delayed by 15 minutes.
How has the Lite Strategy share price performed this year?
Shares in Lite Strategy last closed at $2.56 and the price had moved by -11.72% over the past 365 days. In terms of relative price strength the Lite Strategy share price has underperformed the S&P500 Index by -23.76% over the past year.
What are the analyst and broker recommendations for Lite Strategy?
The overall consensus recommendation for Lite Strategy is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Lite Strategy dividend yield?
Lite Strategy does not currently pay a dividend.
Does Lite Strategy pay a dividend?
Lite Strategy does not currently pay a dividend.
When does Lite Strategy next pay dividends?
Lite Strategy does not currently pay a dividend.
How do I buy Lite Strategy shares?
To buy shares in Lite Strategy you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Lite Strategy?
As of the previous close price of $2.56, shares in Lite Strategy had a market capitalisation of $84.06m.
Where are Lite Strategy shares listed?
Here are the trading details for Lite Strategy:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: LITS
What kind of share is Lite Strategy?
Based on an overall assessment of its quality, value and momentum Lite Strategy is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Lite Strategy share price forecast for 2025?
The analyst consensus target price for shares in Lite Strategy is $6.00. That is 134.38% above the last closing price of $2.56.
Analysts covering Lite Strategy currently have a consensus Earnings Per Share (EPS) forecast of -$6.28 for the next financial year.
Find out moreWhat is the trend in the Lite Strategy share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Lite Strategy. Over the past six months, its share price has underperformed the S&P500 Index by -7.98%.
As of the last closing price of $2.56, shares in Lite Strategy were trading -12.92% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Lite Strategy PE Ratio?
The Lite Strategy PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $2.56.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Lite Strategy?
Lite Strategy's management team is headed by:
- Christine White - NEC
- Daniel Gold - CEO
- David Urso - COO
- Yomara Gomez-Naiden - SVP
- Alejandro Ricart - SVP
- Richard Ghalie - OTH
- Sujay Kango - DRC
- Charles Baltic - IND
- Cheryl Cohen - IND
- Frederick Driscoll - IND
- Nicholas Glover - IND
- Tamar Howson - IND
- Thomas Reynolds - IND